Clinical Trial Update: A Study to Examine the Efficacy and Safety of Posaconazole When Introduced Early in the Treatment of Refractory Fungal Infections (P05090 AM2) [Phase 2]

View source ↗

Summary

Phase 2 study evaluating early use of posaconazole in treating refractory fungal infections; results assessing efficacy and safety were posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Fungal Infections

Drugs mentioned

• POSACONAZOLE (POSACONAZOLE)

Snippet

Sponsor: Merck Sharp & Dohme LLC | Conditions: Mycoses | Phase 2 | Status: COMPLETED | Results posted: 2013-12-27